Literature DB >> 17514636

Excision biopsy of breast lesions changes the pattern of lymphatic drainage.

S H Estourgie1, R A Valdés Olmos, O E Nieweg, C A Hoefnagel, E J T Rutgers, B B R Kroon.   

Abstract

BACKGROUND: The aim was to validate the sentinel node biopsy procedure in women who had previous breast excision biopsy by means of determining the reproducibility of lymphoscintigraphy after surgery.
METHODS: Twenty-five women scheduled for excision biopsy of a breast lesion were investigated. The day before surgery, (99m)Tc-labelled nanocolloid was injected into the tumour. Lymphoscintigraphy was repeated a minimum of 2 weeks after surgery.
RESULTS: Preoperative lymphoscintigraphy visualized at least one sentinel node in all 25 women. Discrepancy in the drainage patterns after surgery was noted in 17 of 25 patients. A change in the drainage pattern in the axilla after excision biopsy was seen in 11 women. Drainage to the internal mammary chain was noted before surgery in 13 women, but only three had the same drainage pathways after excision biopsy.
CONCLUSION: After breast excision biopsy lymphoscintigraphy usually showed a different drainage pattern. This implies that sentinel node biopsy should be performed before excision biopsy to ensure optimal sensitivity. Copyright (c) 2007 British Journal of Surgery Society Ltd. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17514636     DOI: 10.1002/bjs.5763

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  8 in total

Review 1.  Individualized image-based lymph node irradiation for prostate cancer.

Authors:  Hanneke J M Meijer; Oscar A Debats; Emile N J Th van Lin; Marco van Vulpen; J Alfred Witjes; Wim J G Oyen; Jelle O Barentsz; Johannes H A M Kaanders
Journal:  Nat Rev Urol       Date:  2013-05-28       Impact factor: 14.432

2.  Lymphatic drainage from the treated versus untreated prostate: feasibility of sentinel node biopsy in recurrent cancer.

Authors:  Lenka Vermeeren; Willem Meinhardt; Henk G van der Poel; Renato A Valdés Olmos
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-07-09       Impact factor: 9.236

3.  Contralateral Axillary Lymph Node Metastases from Breast Carcinoma: Is it Time to Review TNM Cancer Staging?

Authors:  Francesca Magnoni; M Colleoni; D Mattar; G Corso; V Bagnardi; S Frassoni; G Santomauro; B A Jereczek-Fossa; P Veronesi; V Galimberti; V Sacchini; M Intra
Journal:  Ann Surg Oncol       Date:  2020-05-21       Impact factor: 5.344

4.  Staging the axilla with selective sentinel node biopsy in patients with previous excision of non-palpable and palpable breast cancer.

Authors:  R Ruano; M Ramos; J R Garcia-Talavera; E Serrano; A De Arriba; J Gonzalez-Orus; M Iglesias; M C Macias
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-02-12       Impact factor: 9.236

5.  Value of sentinel lymph node biopsy in breast cancer patients with previous excisional biopsy.

Authors:  Gokhan Coskun; Lutfi Dogan; Niyazi Karaman; Cihangir Ozaslan; Can Atalay
Journal:  J Breast Cancer       Date:  2012-03-28       Impact factor: 3.588

6.  Impact of Tumor Localization and Method of Preoperative Biopsy on Sentinel Lymph Node Mapping After Periareolar Nuclide Injection.

Authors:  Julia Krammer; Anja Dutschke; Clemens G Kaiser; Andreas Schnitzer; Axel Gerhardt; Julia C Radosa; Joachim Brade; Stefan O Schoenberg; Klaus Wasser
Journal:  PLoS One       Date:  2016-02-11       Impact factor: 3.240

7.  Should Internal Mammary Lymph Node Biopsy be A Routine Step in Recurrent Breast Cancer? Report of Three Cases With Negative Axilla and Positive Internal Mammary Node.

Authors:  Stavros E Chatzopoulos; Kasim A Behranwala; Parveen Jayia; Ragheed Al-Mufti R; Susan J Cleator; Dimitri J Hadjiminas
Journal:  World J Oncol       Date:  2011-12-19

8.  Central neck lymph node metastasis in oral squamous cell carcinoma at the floor of mouth.

Authors:  Songtao Zhang; Runfang Zhang; Chao Wang; Wenbo Gong; Miaomiao Xue; Lina Liu; Yuanyuan Zhang
Journal:  BMC Cancer       Date:  2021-03-05       Impact factor: 4.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.